Search research articles
Contact Us
Filters
Showing results (21-30 of 57) with videos related to
Page
of 6
Sort By:
Journal of Clinical Medicine
|
June 26, 2025
Focusing on Selinexor for Holding and Bridging Prior to CAR-T in Relapsed/Refractory Multiple Myeloma
Jack Khouri, Douglas Sborov, Adriana Rossi, et al.
The Neurohospitalist
|
April 14, 2022
Cerebral Venous Sinus Thrombosis due to Thrombosis with Thrombocytopenia Syndrome Following Ad26.COV2.S: A First Real-World Case Report of a Male Subject
Samia Asif, Meghana Kesireddy, Scott A Koepsell, et al.
Hematology/Oncology Clinics of North America
|
November 19, 2011
Curing all patients with acute promyelocytic leukemia: are we there yet?
Muhamed Baljevic, Jae H Park, Eytan Stein, et al.
Ejhaem
|
June 17, 2026
Real-World Diagnostic Workup of Patients Suspected for Light Chain Amyloidosis and Wild-Type Transthyretin Amyloid Cardiomyopathy: A Retrospective Cohort Study Using US Electronic Health Records
Muhamed Baljevic, Haechung Chung, Jose Alvir, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE
|
April 28, 2023
Development and implementation of "handshake rounds": An antibiotic stewardship intervention for hospitalized adult patients with hematologic malignancies
Chelsea A Gorsline, Ryan M Miller, Laura J Bobbitt, et al.
Ejhaem
|
December 18, 2024
Real-world practitioner perceptions of CARTITUDE-4 results for patients with previously treated multiple myeloma
Alexandrina Balanean, Samuel Baird, Brooke Dulka, et al.
Frontiers in Oncology
|
May 1, 2026
Bone-modifying therapy in multiple myeloma: a comprehensive review
Martina Bogeljić Patekar, Vibor Milunović, Inga Mandac Smoljanović, et al.
Frontiers in Oncology
|
June 3, 2024
Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
Darrell White, Gary J Schiller, Sumit Madan, et al.
Acta Haematologica
|
November 14, 2012
Translocation t(11;17) in de novo myelodysplastic syndrome not associated with acute myeloid or acute promyelocytic leukemia
Muhamed Baljevic, Omar Abdel-Wahab, Raajit Rampal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 6, 2022
Optimizing Thromboembolism Prophylaxis for the Contemporary Age of Multiple Myeloma
Muhamed Baljevic, Douglas W Sborov, Ming Y Lim, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 57) with videos related to
Sort By:
Page
of 6
Journal of Clinical Medicine
|
June 26, 2025
Focusing on Selinexor for Holding and Bridging Prior to CAR-T in Relapsed/Refractory Multiple Myeloma
Jack Khouri, Douglas Sborov, Adriana Rossi, et al.
The Neurohospitalist
|
April 14, 2022
Cerebral Venous Sinus Thrombosis due to Thrombosis with Thrombocytopenia Syndrome Following Ad26.COV2.S: A First Real-World Case Report of a Male Subject
Samia Asif, Meghana Kesireddy, Scott A Koepsell, et al.
Hematology/Oncology Clinics of North America
|
November 19, 2011
Curing all patients with acute promyelocytic leukemia: are we there yet?
Muhamed Baljevic, Jae H Park, Eytan Stein, et al.
Ejhaem
|
June 17, 2026
Real-World Diagnostic Workup of Patients Suspected for Light Chain Amyloidosis and Wild-Type Transthyretin Amyloid Cardiomyopathy: A Retrospective Cohort Study Using US Electronic Health Records
Muhamed Baljevic, Haechung Chung, Jose Alvir, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE
|
April 28, 2023
Development and implementation of "handshake rounds": An antibiotic stewardship intervention for hospitalized adult patients with hematologic malignancies
Chelsea A Gorsline, Ryan M Miller, Laura J Bobbitt, et al.
Ejhaem
|
December 18, 2024
Real-world practitioner perceptions of CARTITUDE-4 results for patients with previously treated multiple myeloma
Alexandrina Balanean, Samuel Baird, Brooke Dulka, et al.
Frontiers in Oncology
|
May 1, 2026
Bone-modifying therapy in multiple myeloma: a comprehensive review
Martina Bogeljić Patekar, Vibor Milunović, Inga Mandac Smoljanović, et al.
Frontiers in Oncology
|
June 3, 2024
Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
Darrell White, Gary J Schiller, Sumit Madan, et al.
Acta Haematologica
|
November 14, 2012
Translocation t(11;17) in de novo myelodysplastic syndrome not associated with acute myeloid or acute promyelocytic leukemia
Muhamed Baljevic, Omar Abdel-Wahab, Raajit Rampal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 6, 2022
Optimizing Thromboembolism Prophylaxis for the Contemporary Age of Multiple Myeloma
Muhamed Baljevic, Douglas W Sborov, Ming Y Lim, et al.
Page
of 6